ArticleNPJ precision oncology2024

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer.

Yan Qin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.